☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Abata Therapeutics
Abata Therapeutics' ABA-101 Gets the US FDA FTD to Treat Progressive Multiple Sclerosis (MS)
August 23, 2024
Abata Therapeutics Receives Investment from BMS for the Advancement of Treg Cell Therapies
August 16, 2024
Abata Therapeutics Reports the US FDA’s IND Clearance for P-I Trial of ABA-101 for Progressive Multiple Sclerosis
July 9, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.